Vitafusion ‘Clinically Proven Absorption’ Claim Fails In C&D Appeal Of Industry Self-Regulation Review
C&D Also Argued NAD Erred In Initial Review Allowing Pharmavite To Expand Challenge
Church & Dwight will comply with National Advertising Review Board decision to discontinue claim for vitafusion supplements. The panel rejected C&D’s argument that any amount of vitamin absorption is “clinically meaningful” and deferred to the National Advertising Division on C&D’s procedural challenge.
You may also be interested in...
In response to Church & Dwight’s Single Well-defined Issue Fast Track challenge at NAD, Pharmavite modifies “clinically proven absorption” claims for Nature Made Multi Complete, Prenatal Multi + DHA Softgels, and Prenatal Gummies by disclosing nutrients clinically tested.
P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.
FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.